US Businessman Pleads Guilty in Massive Healthcare Fraud Case
A North Carolina businessman has pleaded guilty in a massive healthcare fraud case involving illegal kickbacks, fabricated COVID-19 test claims, stolen physician identities, and tax fraud that allegedly generated tens of millions of dollars in fraudulent public healthcare reimbursements.
James Shuford Price III, 59, of Raleigh, admitted before a federal court to paying illegal referral kickbacks to obtain medical specimens for his California-based laboratory, Golden Star Labs (GSL), and to filing a false federal income tax return.
According to US federal prosecutors, the fraudulent operation submitted more than $96 million in false healthcare claims while exploiting Medicare and California's Medi-Cal program.
Millions of Dollars in False Medicare and Medi-Cal Claims
According to court documents, Price owned and operated Golden Star Labs, a diagnostic testing laboratory based in Los Angeles.
Between August 2023 and June 2025, prosecutors allege that the laboratory submitted:
- More than $85 million in fraudulent claims to California's Medi-Cal program.
- More than $11 million in false claims to Medicare.
Authorities claim the operation relied on fabricated medical documentation, identity theft, and unlawful financial incentives to generate reimbursement payments from government-funded healthcare programs.
Illegal Kickbacks Fueled the Testing Network
Investigators say Golden Star Labs built a structured referral network by recruiting third-party specimen collectors across California.
According to prosecutors, these collectors were paid based on the number of patient specimens they delivered—a compensation model prohibited under federal healthcare fraud laws.
Between August 2023 and January 2025, the laboratory allegedly paid more than $17 million in illegal kickbacks.
The collectors then supplied thousands of test samples that investigators allege were connected to fraudulent identities and fabricated medical authorizations.
Federal investigators further alleged that during the first six months of the scheme, approximately 96 percent of the laboratory's Medi-Cal claims relied on forged authorizations linked to the stolen identity of a single out-of-state physician.
Investigators Allege Widespread Identity Theft
Authorities claim the fraud continued even after internal billing concerns emerged.
According to prosecutors, laboratory operations briefly paused in February 2024 before resuming the following month using essentially the same methods.
From March 2024 through January 2025, investigators allege that nearly 92 percent of Medi-Cal claims submitted by Golden Star Labs were supported by fraudulent medical authorizations created using the stolen identities of five different healthcare professionals.
To conceal the arrangement, prosecutors say the laboratory created written contracts showing fixed-fee agreements while allegedly continuing to pay collectors based on specimen volume behind the scenes.
FBI Seizes Millions During Investigation
The investigation, led jointly by the FBI and the US Attorney's Office, resulted in the seizure of more than $6 million in assets allegedly connected to the fraud.
Price also admitted filing a false federal income tax return for the 2022 tax year, after investigators determined he failed to report income obtained from multiple sources, including proceeds from an earlier investment fraud scheme.
Federal authorities continue to examine financial records associated with the broader operation.
Potential Prison Sentence and Restitution
Price is scheduled to be sentenced in federal court, where he faces:
- Up to 13 years in federal prison
- A maximum $500,000 criminal fine
- Three years of supervised release
In addition, prosecutors are seeking full restitution to:
- Centers for Medicare & Medicaid Services (CMS)
- California Medi-Cal Program
- Internal Revenue Service (IRS)
US Attorney Ellis Boyle stated that healthcare fraud diverts taxpayer-funded resources intended for legitimate patients and pledged continued enforcement against large-scale medical fraud schemes.
FBI Special Agent in Charge Reid Davis described the operation as a serious breach of public trust and emphasized the Bureau's commitment to dismantling healthcare fraud networks.
Why This Case Matters
Healthcare fraud continues to represent one of the largest sources of financial loss to public healthcare systems worldwide.
Cases involving stolen physician identities, fabricated medical testing, illegal referral payments, and false insurance billing not only drain taxpayer funds but can also undermine trust in healthcare delivery systems.
The prosecution of James Shuford Price highlights the increasing use of forensic financial analysis, digital evidence, and inter-agency cooperation to detect sophisticated healthcare fraud operations.
Shunyatax Global Insight
The Golden Star Labs case demonstrates how organized healthcare fraud can combine identity theft, illegal kickback arrangements, fraudulent billing practices, and tax evasion into a single large-scale criminal enterprise. As governments invest billions in public healthcare programs, regulatory agencies are increasingly relying on advanced financial analytics and digital investigations to identify and prosecute complex medical fraud schemes.
For more exclusive coverage on financial crime, healthcare fraud, cybersecurity, legal enforcement, and global investigations, visit:
https://www.shunyataxglobal.com/
Make Shunyatax Global News Media your trusted source for investigative journalism, cyber intelligence, legal affairs, and public-interest reporting.